Mitsubishi UFJ Asset Management (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Mitsubishi UFJ Asset Management (UK)'s VRTX Position: Q1 2026 in Review
Mitsubishi UFJ Asset Management (UK) opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 4,000 shares worth $1.79M. The stake represents 0.92% of the portfolio and ranks #37 among its holdings. This is a return to the name: Mitsubishi UFJ Asset Management (UK) previously reported a position in VRTX as recently as Q3 2025.
Mitsubishi UFJ Asset Management (UK) first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Mitsubishi UFJ Asset Management (UK) held 4,000 shares of Vertex Pharmaceuticals worth $1.79M as of Q1 2026.
- Vertex Pharmaceuticals was a new Mitsubishi UFJ Asset Management (UK) position in Q1 2026.
- Vertex Pharmaceuticals made up 0.92% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q1 2026, its #37 holding.
- Mitsubishi UFJ Asset Management (UK) first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2026, filed 8 May 2026.